|
C9ORF93 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73959957550096E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19669999465444E-08 |
| Normal-vs-Stage2 |
3.370600E-04 |
| Normal-vs-Stage3 |
3.53269999999739E-05 |
| Normal-vs-Stage4 |
3.95020000000246E-05 |
| Stage1-vs-Stage2 |
8.697600E-01 |
| Stage1-vs-Stage3 |
6.785200E-01 |
| Stage1-vs-Stage4 |
3.245800E-01 |
| Stage2-vs-Stage3 |
8.745200E-01 |
| Stage2-vs-Stage4 |
3.484800E-01 |
| Stage3-vs-Stage4 |
1.801780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56199497780563E-11 |
| Normal-vs-AfricanAmerican |
7.70350000000031E-05 |
| Normal-vs-Asian |
4.05800000000678E-05 |
| Caucasian-vs-AfricanAmerican |
3.705600E-01 |
| Caucasian-vs-Asian |
1.926620E-01 |
| AfricanAmerican-vs-Asian |
8.645000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63369318073592E-12 |
| Normal-vs-Female |
2.137500E-03 |
| Male-vs-Female |
1.351420E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.92150000000369E-05 |
| Normal-vs-Extreme_Weight |
2.13884465694036E-12 |
| Normal-vs-Obese |
2.47819999965593E-07 |
| Normal-vs-Extreme_Obese |
3.762700E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.995600E-02 |
| Normal_Weight-vs-Obese |
8.686200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.507800E-01 |
| Extreme_Weight-vs-Obese |
2.352200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.214600E-01 |
| Obese-vs-Extreme_Obese |
9.769400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.026400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.63440000422455E-08 |
| Normal-vs-Age(61-80Yrs) |
1.13109999144712E-09 |
| Normal-vs-Age(81-100Yrs) |
8.96310003994927E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.259580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.826000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.900300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.285200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.097700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.128000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72972747236599E-12 |
| Normal-VS-Type2 PRCC |
7.27039999981471E-07 |
| Normal-VS-KIRP CIMP |
1.357380E-01 |
| Normal-VS-Unclassified PRCC |
3.559700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.093000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.060400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.366300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.644500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.500200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.712200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.3162999991716E-08 |
| Normal-vs-N1 |
3.53899999999685E-05 |
| Normal-vs-N2 |
3.636100E-03 |
| N0-vs-N1 |
6.514800E-01 |
| N0-vs-N2 |
4.750000E-01 |
| N1-vs-N2 |
3.202400E-01 |
|
|
